HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 148 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $584,561 | +3.0% | 17,408 | -0.9% | 0.00% | 0.0% |
| Q4 2023 | $567,285 | -4.5% | 17,563 | -3.1% | 0.00% | -50.0% |
| Q3 2023 | $594,022 | -3.8% | 18,127 | +3.3% | 0.00% | 0.0% |
| Q2 2023 | $617,409 | +30.1% | 17,545 | +20.7% | 0.00% | +33.3% |
| Q1 2023 | $474,470 | -40.6% | 14,532 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $798,619 | +23.4% | 14,494 | -0.8% | 0.01% | +20.0% |
| Q3 2022 | $647,000 | -5.0% | 14,609 | +4.6% | 0.01% | 0.0% |
| Q2 2022 | $681,000 | +6.4% | 13,971 | +6.3% | 0.01% | +25.0% |
| Q1 2022 | $640,000 | +7.6% | 13,149 | -5.8% | 0.00% | +33.3% |
| Q4 2021 | $595,000 | +26.9% | 13,955 | +14.1% | 0.00% | 0.0% |
| Q3 2021 | $469,000 | +32.5% | 12,234 | -2.3% | 0.00% | +200.0% |
| Q2 2021 | $354,000 | +195.0% | 12,525 | +246.0% | 0.00% | – |
| Q1 2021 | $120,000 | -8.4% | 3,620 | +0.3% | 0.00% | – |
| Q4 2020 | $131,000 | – | 3,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |